Gara Jalqabaatti › Colitis Ulcerative › New York

Qorannoo klinikaalii Colitis Ulcerative New York keessatti

Qorannoo 30 Colitis Ulcerative f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

New York Gastroenterology Associates - Upper East Side /ID# 281767, New York

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

New York Gastroenterology Associates ( Site 0253), New York

Namoota walitti qabaa jiraSadarkaa 3

Umuriin hundi · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06651281

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ellipsis Research Group, Brooklyn
Smart Medical Research - Jackson Heights, Jackson Heights
Pioneer Clinical Research NY, New York
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06598943

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Westchester Putnam Gastroenterology PC, Carmel
Five Towns Gastroenterology, Cedarhurst
IMIDeology, Elmhurst
fi 5 dabalataa

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06581328

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Site US-002, Albany
Site US-016, Rochester

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07845487

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Site 037, New York

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07012395

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Xencor Investigative Site, Albany
Xencor Investigative Site, Rochester

Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06619990

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Intercity Gastroenterology, Fresh Meadows

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Westchester Putnam Gastroenterology, Carmel
Inflammatory Bowel Disease Center at NYU Langone, New York
Icahn School of Medicine at Mount Sinai, New York
fi 3 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 12 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Columbia University Medical Center, New York

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Icahn School of Medicine at Mount Sinai, New York
New York Gastroenterology Associates, New York
Care Access - Yonkers, Yonkers

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Stony Brook University, Stony Brook

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07415044

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Icahn School of Medicine at Mount Sinai, New York

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 2 hanga 19 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT04844606

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Digestive Disease Medicine of Central New York, Utica

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07186101

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NYU Langone Health, New York
Weill Cornell Medical College- New York Presbyterian Hospital, New York

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

MedTraits NY - Site Number: 8400045, Maspeth
Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
New York Gastroenterology Associates - Site Number: 8400009, New York

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

New York Gastroenterology Associates, New York

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07577856

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

Fink Children's Ambulatory Care Center, New York
Kimmel Pavilion - NYU Langone, New York
NYU Grossman School of Medicine, New York
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 2 hanga 11 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT07470879

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Columbia University Medical Center, New York

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

MedTraits NY - Site Number: 8400045, Maspeth
Manhattan Clinical Research, LLC - Site Number: 8400069, New York
NYU Langone Health - Site Number: 8400091, New York
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Saratoga Schenectady Gastroenterology Associates, Burnt Hills
NYU Langone Health, New York
Cornell University, New York

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

Northwell Health North Shore University Hospital, Manhasset
Columbia University Irving Medical Center/New York Presbyterian Hospital, New York

Namoota walitti qabaa jira

Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06571669

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

New York University, New York

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

NYU Langone Health, New York
Lenox Hill Hospital, Northwell Health, New York

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT06398626

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

New York Presbyterian Hospital, New York

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT06405087

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, New York
Mirador Therapeutics Selected Site, Rochester

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 12-Bit-2026 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

State University of New York Upstate Medical University, Syracuse

Namoota walitti qabaa jira

Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 08-Ama-2026 · NCT05987852

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Bausch Health Site 006, The Bronx

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 5 hanga 17 · Saalaa hunda · Haaromfame 16-Ful-2025 · NCT04314375

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

New York University, New York

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Cam-2025 · NCT06750731

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.